Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized phase II, placebo-controlled trial
在新加坡完成四价登革热疫苗基础免疫5年以上后,接种加强剂的体液和细胞免疫原性及安全性:一项随机II期安慰剂对照试验的2年随访结果
期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2020.1861875
Park, Juliana; Archuleta, Sophia; Oh, May-Lin Helen; Shek, Lynette Pei-Chi; Wang, Hao; Bonaparte, Matthew; Frago, Carina; Bouckenooghe, Alain; Jantet-Blaudez, Frederique; Begue, Sarah; Gimenez-Fourage, Sophie; Pagnon, Anke